Document Detail

Role of oxidative stress in hypoxia preconditioning of cells transplanted to the myocardium: a molecular imaging study.
MedLine Citation:
PMID:  21792164     Owner:  NLM     Status:  MEDLINE    
AIM: Cell-based therapies are a potential therapeutic alternative for the treatment of coronary artery disease (CAD). However, transplanted cells undergo significant death in the living subject. Hypoxic preconditioning (HPC) is a potential intervention to increase transplanted cell survival. However, the biological mechanisms of this benefit remain unclear. We hypothesize that the beneficial effect of HPC on stem cell survival is in part due to preservation of oxidant status, an effect that will be monitored using state-of-the-art molecular imaging.
METHODS: H9c2 rat cardiomyoblasts expressing the construct CMV-firefly luciferase (h9c2-fluc), with and without HPC, were exposed to hypoxia, and oxidative stress and cell survival were measured. Subsequently, H9c2-fluc cells, with and without HPC, were injected into the myocardium of rats and cell survival was monitored daily with Bioluminescence (BLI) using a CCD camera.
RESULTS: Compared to controls, cells exposed to hypoxia had increased amount of reactive oxygen species (ROS, control: 14.1±0.9 vs. hypoxia: 19.5 ± 2.0 RFU/µg protein, P=0.02) and decreased cell survival (control: 0.29 ± 0.005 vs. hypoxia: 0.24 ± 0.005 OD, P<0.001). HPC treatment decreased the amount of hypoxia-induced ROS (HPC: 11.5 ± 0.7RFU/µg protein, P=0.002 vs. hypoxia and P=0.11 vs. control), associated with improved survival (HPC: 0.27 ± 0.004OD/µg protein, P=0.002 vs. hypoxia and P=0.005 vs. control). Most importantly, compared to un-conditioned cells, HPC-cells had increased cell survival after transplantation to the myocardium (C: 34.7 ± 6.7% vs. HPC: 83.4 ± 17.5% at day 5 compared to day 1, P=0.01).
CONCLUSION: The beneficial effect of HPC is in part due to preservation of oxidant status. Molecular imaging can assess changes in cell survival in the living subject and has the potential to be applied clinically.
A Aly; K Peterson; A Lerman; L Lerman; M Rodriguez-Porcel
Related Documents :
6621694 - Correction of cell-cell communication defect by introduction of a protein kinase into m...
20573814 - Elevated cyclic amp levels in t lymphocytes transformed by human t-cell lymphotropic vi...
2097004 - The stroma-vascular fraction of rat inguinal and epididymal adipose tissue and the adip...
2159014 - Effect of cyclic amp on the cell cycle regulation of ribonucleotide reductase m2 subuni...
21029414 - Cell-free mirnas may indicate diagnosis and docetaxel sensitivity of tumor cells in mal...
21871644 - Interconverting flavanone glucosides and other phenolic compounds in lippia salviaefoli...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of cardiovascular surgery     Volume:  52     ISSN:  0021-9509     ISO Abbreviation:  J Cardiovasc Surg (Torino)     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-07-27     Completed Date:  2011-11-15     Revised Date:  2014-09-09    
Medline Journal Info:
Nlm Unique ID:  0066127     Medline TA:  J Cardiovasc Surg (Torino)     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  579-85     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Hypoxia
Cell Line
Cell Survival
Cell Tracking* / methods
Cytomegalovirus / genetics
Genes, Reporter
Luciferases, Firefly / biosynthesis,  genetics
Luminescent Measurements
Myocardium / metabolism*,  pathology
Myocytes, Cardiac / metabolism,  pathology,  transplantation*
Oxidative Stress*
Rats, Sprague-Dawley
Reactive Oxygen Species / metabolism*
Time Factors
Grant Support
Reg. No./Substance:
0/Reactive Oxygen Species; EC, Firefly

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Visceral artery aneurysms: management of 48 cases.
Next Document:  Quality of life one year post myocardial revascularization and aortic valve replacement in patients ...